Always on point you know where it's at!
Dr. Zitzmann gets deep here!
Key Take Home Point!
* The clinically responsible synthesis is therefore precise: genotype may modify interpretation, but it does not yet rewrite the diagnosis of hypogonadism. A continuous CAG 15–35 × TT/FT response surface...
Abstract
INTRODUCTION AND OBJECTIVES:
The preferred treatment for hypogonadism, testosterone replacement therapy (TRT), has a varying efficacy that is currently not understood. This observation may be explained by polymorphism of the androgen receptor (AR), a ligand-binding transcription factor...